ArticleThe Journal of clinical investigation2017

Targeting the adenosine 2A receptor enhances chimeric antigen receptor T cell efficacy.

Paul A Beavis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.